Grape King Bio Ltd (TPE:1707)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
119.50
-0.50 (-0.42%)
At close: Mar 13, 2026

Grape King Bio Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,25211,16010,63510,3919,798
Revenue Growth (YoY)
-8.14%4.93%2.35%6.05%6.87%
Cost of Revenue
2,5552,5022,0991,9091,942
Gross Profit
7,6978,6588,5368,4827,856
Selling, General & Admin
5,2815,8665,7475,6395,252
Research & Development
274.66291.91289.55289.88292.23
Other Operating Expenses
-0.520.022.481.10.57
Operating Expenses
5,5556,1586,0395,9305,544
Operating Income
2,1422,5002,4972,5522,312
Interest Expense
-4.75-3.04-2.54-2.29-3.93
Interest & Investment Income
46.1549.9747.619.926.29
Earnings From Equity Investments
28.7222.2419.8710.822.23
Currency Exchange Gain (Loss)
---11.63-2.24
Other Non Operating Income (Expenses)
86.07104.399.0294.199.35
EBT Excluding Unusual Items
2,2982,6732,6612,6862,413
Gain (Loss) on Sale of Investments
----1.910.8
Gain (Loss) on Sale of Assets
---3.760.82
Other Unusual Items
---0.11-
Pretax Income
2,2982,6732,6612,6882,415
Income Tax Expense
436.77502.15519.11518.19466.92
Earnings From Continuing Operations
1,8612,1712,1422,1701,948
Minority Interest in Earnings
-642.63-722.85-688.78-712.58-647.57
Net Income
1,2181,4481,4531,4571,300
Net Income to Common
1,2181,4481,4531,4571,300
Net Income Growth
-15.88%-0.30%-0.30%12.05%2.23%
Shares Outstanding (Basic)
148148148148148
Shares Outstanding (Diluted)
149149149149148
Shares Change (YoY)
-0.02%0.00%0.06%0.45%8.41%
EPS (Basic)
8.229.789.819.848.81
EPS (Diluted)
8.179.719.749.788.76
EPS Growth
-15.86%-0.31%-0.41%11.64%-5.71%
Free Cash Flow
1,7341,2491,9322,5042,267
Free Cash Flow Per Share
11.638.3812.9616.8015.28
Dividend Per Share
-6.9006.9006.9006.100
Dividend Growth
---13.11%-4.69%
Gross Margin
75.08%77.58%80.26%81.63%80.18%
Operating Margin
20.89%22.40%23.47%24.56%23.59%
Profit Margin
11.88%12.98%13.66%14.02%13.27%
Free Cash Flow Margin
16.92%11.19%18.17%24.09%23.14%
EBITDA
2,6983,0132,9562,9362,679
EBITDA Margin
26.32%27.00%27.80%28.26%27.34%
D&A For EBITDA
556.55513.48459.76384.63367.68
EBIT
2,1422,5002,4972,5522,312
EBIT Margin
20.89%22.40%23.47%24.56%23.59%
Effective Tax Rate
19.01%18.78%19.51%19.28%19.34%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.